Stock ENLV ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/07/2024 BST 		5-day change 1st Jan Change
1.38 USD -2.82% Intraday chart for Enlivex Therapeutics Ltd. -2.13% -48.89%
06-24 Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial MT
06-24 Enlivex Therapeutics Ltd. Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ENLIVEX THERAPEUTICS LTD.
Bio Therapeutic Drugs
-2.82%-2.13%-48.89%-46.82%-93.58% 29.64M
Bullish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Charts Enlivex Therapeutics Ltd.
  5. Relative Strength Chart